CA1047922A - Live influenza virus vaccines and preparation thereof - Google Patents

Live influenza virus vaccines and preparation thereof

Info

Publication number
CA1047922A
CA1047922A CA218,508A CA218508A CA1047922A CA 1047922 A CA1047922 A CA 1047922A CA 218508 A CA218508 A CA 218508A CA 1047922 A CA1047922 A CA 1047922A
Authority
CA
Canada
Prior art keywords
virus
strain
atcc
influenza type
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA218,508A
Other languages
English (en)
French (fr)
Other versions
CA218508S (en
Inventor
Emil Vascoboinic
Jean-Marie Prevost
Julien Peetermans
Michele Lobmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RECHERCHE ET INDUSTRIE THERAPEUTIQUES RIT
Original Assignee
RECHERCHE ET INDUSTRIE THERAPEUTIQUES RIT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RECHERCHE ET INDUSTRIE THERAPEUTIQUES RIT filed Critical RECHERCHE ET INDUSTRIE THERAPEUTIQUES RIT
Application granted granted Critical
Publication of CA1047922A publication Critical patent/CA1047922A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA218,508A 1974-02-04 1975-01-23 Live influenza virus vaccines and preparation thereof Expired CA1047922A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43917674A 1974-02-04 1974-02-04

Publications (1)

Publication Number Publication Date
CA1047922A true CA1047922A (en) 1979-02-06

Family

ID=23743623

Family Applications (1)

Application Number Title Priority Date Filing Date
CA218,508A Expired CA1047922A (en) 1974-02-04 1975-01-23 Live influenza virus vaccines and preparation thereof

Country Status (21)

Country Link
JP (1) JPS50107122A (ja)
AT (1) AT338416B (ja)
BE (1) BE824970A (ja)
CA (1) CA1047922A (ja)
CH (1) CH596316A5 (ja)
CS (1) CS202545B2 (ja)
DD (1) DD116474A5 (ja)
DE (1) DE2504373A1 (ja)
DK (1) DK141926B (ja)
ES (1) ES434384A1 (ja)
FI (1) FI750260A (ja)
FR (1) FR2259616B1 (ja)
GB (1) GB1439742A (ja)
HU (1) HU170522B (ja)
IE (1) IE42043B1 (ja)
IL (1) IL46446A (ja)
LU (1) LU71784A1 (ja)
NL (1) NL7501028A (ja)
NO (1) NO750295L (ja)
SE (1) SE424503B (ja)
ZA (1) ZA75248B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2588918A (en) * 1947-11-07 1952-03-11 William T Graham Mechanism for raising and lowering plow frames relative to the ground wheels
JPS6042209B2 (ja) * 1974-05-31 1985-09-20 北里研究所（社団法人） インフルエンザウイルスの新鮮分離株を発育鶏卵へ短期間で順化させる方法

Also Published As

Publication number Publication date
ES434384A1 (es) 1976-12-01
DK141926B (da) 1980-07-21
IE42043L (en) 1975-08-04
BE824970A (fr) 1975-07-30
ZA75248B (en) 1976-01-28
LU71784A1 (ja) 1975-06-24
IL46446A (en) 1978-01-31
HU170522B (ja) 1977-06-28
CH596316A5 (ja) 1978-03-15
SE7500549L (ja) 1975-08-05
IE42043B1 (en) 1980-05-21
CS202545B2 (en) 1981-01-30
FR2259616B1 (ja) 1980-01-04
SE424503B (sv) 1982-07-26
IL46446A0 (en) 1975-04-25
GB1439742A (en) 1976-06-16
AU7734675A (en) 1976-07-15
ATA76675A (de) 1976-12-15
NL7501028A (nl) 1975-08-06
FI750260A (ja) 1975-08-05
DK141926C (ja) 1981-01-19
DE2504373A1 (de) 1975-08-07
DD116474A5 (ja) 1975-11-20
JPS50107122A (ja) 1975-08-23
DK9775A (ja) 1975-09-29
FR2259616A1 (ja) 1975-08-29
AT338416B (de) 1977-08-25
NO750295L (ja) 1975-09-01

Similar Documents

Publication Publication Date Title
US6045790A (en) Vaccines for equine influenza
PERKINS et al. Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route
Clements et al. Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine
US4009258A (en) Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same
US4338296A (en) Influenza virus and process of producing a vaccine therefrom
Potter et al. Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines
Winterfield et al. Newcastle Disease Immunization Studies: 4. Vaccination of Chickens with B1, F and Lasota Strains of Newcastle Disease Virus Administered through the Drinking Water
US4235876A (en) Live Newcastle disease virus vaccine
AU613012B2 (en) Influenza vaccine
US4318903A (en) Live influenza virus vaccine and the preparation thereof
Kilbourne et al. Influenza vaccines: Summary of influenza workshop V
US3953592A (en) Live influenza virus vaccines and preparation thereof
Kendal et al. Laboratory-based surveillance of influenza virus in the United States during the winter of 1977–1978: II. Isolation of a mixture of A/Victoria-and A/USSR-like viruses from a single person during an epidemic in Wyoming, USA, January 1978
US3962423A (en) Live influenza type B virus vaccines and preparation thereof
CA1047922A (en) Live influenza virus vaccines and preparation thereof
CA1044138A (en) Recombinant influenza virus strains for vaccines
Van Kirk et al. Evaluation of low temperature grown influenza A2/Hong Kong virus in volunteers
Van Voorthuizen et al. Characterization and clinical evaluation of live influenza A vaccine prepared from a recombinant of the A/USSR/92/77 (H1N1) and the cold-adapted A/Ann Arbor/6/60 (H2N2) strains
CA1152895A (en) Process for the preparation of novel influenza virus strains and influenza virus vaccines containing them
Rytel et al. New live attenuated influenza A/England/42/72 (H3N2) vaccine (Alice): reactogenicity, immunogenicity, and protection efficacy
Clements et al. Comparison of the virologic and immunologic responses of volunteers to live avian-human influenza A H3N2 reassortant virus vaccines derived from two different avian influenza virus donors
Winterfield et al. Vaccination of turkeys against Newcastle disease
US7041299B2 (en) Escape mutants of newcastle disease virus as marker vaccines
Delem et al. Genotypic characterization and clinical evaluation of the attenuated A/California/10/78 (H1N1) recombinant strain RIT 4265
Lobmann et al. Recombinants of influenza virus type B as potential live vaccine candidates: RNA characterization and evaluation in man